Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Birrell

Mark Andrew Birrell, Upminster GB

Patent application numberDescriptionPublished
20110112178Compositions And Methods For Inhibiting Expression Of IKK-B Gene - The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of the IKK-B gene, comprising an antisense strand having a nucleotide sequence which is less that 30 nucleotides in length, generally 19-25 nucleotides in length, and which is substantially complementary to at least a part of the IKK-B gene. The invention also relates to a pharmaceutical composition comprising the dsRNA together with a pharmaceutically acceptable carrier; methods for treating diseases caused by the expression or activation of the IKK-B gene using the pharmaceutical composition; and methods for inhibiting the expression of the IKK-B gene in a cell.05-12-2011

Michael Ian Birrell, Hartfordshire GB

Patent application numberDescriptionPublished
20090053458Composite Material - A formed thermoplastics composite sheet (02-26-2009

Michael Ian Birrell, Hertfordshire GB

Patent application numberDescriptionPublished
20080233342Recyclable Composite Plastic for Automotive Headliner - A method of producing a panel having at least one feature comprising a discontinuation in curvature of surface in the surface, the method comprising the steps of: providing a first reinforced layer of long and/or continuous parallel fibre reinforced thermoplastic of a first polymer (09-25-2008
20120021166Recyclable Composite Plastic Panel - A method of producing a panel having at least one feature comprising a discontinuation in curvature of surface in the surface, the method comprising the steps of: providing a first reinforced layer of long and/or continuous parallel fibre reinforced thermoplastic of a first polymer (01-26-2012

Stephen N. Birrell, Medindie AU

Patent application numberDescriptionPublished
20120122824Reduction of Side Effects From Aromatase Inhibitors Used for Treating Breast Cancer - The present invention is directed generally to pharmaceutical compositions, methods, and kits for improving side effects associated with aromatase inhibitor treatment in a subject diagnosed with breast cancer. More specifically, the present invention provides compositions, methods, and kits comprising an aromatase inhibitor and an androgenic agent.05-17-2012

Stephen Nigel Birrell, South Australia AU

Patent application numberDescriptionPublished
20090215731Reduction of Side Effects From Aromatase Inhibitors Used for Treating Breast Cancer - The present invention is directed generally to pharmaceutical compositions, methods, and kits for improving side effects associated with aromatase inhibitor treatment in a subject diagnosed with breast cancer. More specifically, the present invention provides compositions, methods, and kits comprising an aromatase inhibitor and an androgenic agent.08-27-2009